Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/2800df3b-b7ca-4baa-85d4-88b4c4f1ec95/
UTMD
Utah Medical Products IncSnapshot 2026-07-26 · 0.6w · Fresh
Strategy Eligibility
9 of 23 passing
★
OS Composite
OS 0.910
↗
Trending Value
✗
◆
Quality × Value
QV 0.822
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
✗
📐
EBITDA/EV
11.6%
◐
Veiled Value
✗
▣
Piotroski Bargains
✗
🔬
Quality Compounders
✗
📈
Consistent Earners
Yes
🌱
GARP
✗
🔄
Shareholder Yield
5.7%
💰
High Yield
✗
🚀
Momentum Leaders
12-1 29%
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
Val 75%
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
CAQ 0.77
⚡
Risk-Adj Momentum
RAM 1.13
V
Value Analysis
Cheapness relative to fundamentals
75.0%ile
P/E
20.4×
P/S
5.9×
P/B
1.8×
E/P
0.0969
FCF Yield
0.119
EBITDA/EV
0.116
SH Yield
0.057
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
69.00000000
/100 — 1=cheapest
VC2 (Trending Value)
35.00000000
/100
VC3 (Buyback)
66.00000000
/100
FCF yield of 11.9% is strong — the business generates significant free cash relative to price.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
90.0%ile
ROE
0.086
ROA
0.084
Net Margin
0.290
Op Margin
0.339
GPA
0.159
D/E
0.02
Current
48.62
F-Score
6/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
-0.070
Earn Growth
-0.165
Stability
0.117
lower=better
Accruals
-0.034
lower=better
5yr Consist
Yes
Conservative balance sheet with D/E of 0.02.
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
69.0%ile
6M Return
10.7%
12M Return
17.0%
12-1 Mom
28.9%
Risk-Adj
1.13
Vol 252d
25.5%
Vol 60d
56.8%
↑ Expanding
Max DD 12M
-12.9%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
12-1 momentum of 29% is very strong — a clear uptrend. Near-term vol (57%) is expanding vs long-term (25%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.91
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare
· 500 peers
Sector Value %ile
86.0%
Sector Quality %ile
90.6%
P/E z-score
-0.12
P/B z-score
-0.23
Sector Avg OS
64.8%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
Factor Interactions
Value + Quality Intersection
Top-tier on both cheapness (75th) and quality (90th) — the O'Shaughnessy sweet spot, historically the strongest long-term combination.
Strong Capital Return
Shareholder yield 5.7% backed by 11.9% FCF yield. Returns are well-funded.
Volatility Expanding
60-day vol (57%) significantly exceeds 252-day (25%). Near-term risk is elevated.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
B
72.6% avg (7 factors)
Quality
B
71.4% avg (8 factors)
Momentum
C
57.0% avg (4 factors)
Risk
B
74.2% avg (1 factors)
This stock sits in the O'Shaughnessy sweet spot — cheap AND high quality. Historically, this combination has generated the strongest long-term returns.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Score Trends8 snapshots
Factor Persistence8 snapshots
| Factor | Current | Streak | Trend | Spark |
|---|---|---|---|---|
| OS Composite | 0.910 | —8 | — | |
| Value %ile | 0.750 | —4 | — | |
| Quality %ile | 0.900 | —8 | — | |
| Momentum %ile | 0.690 | —0 | — | |
| F-Score | 6.000 | —0 | — | |
| Confidence | 1.000 | —8 | — | |
| Volatility | 0.255 | —0 | — |
Value Lens2021-07-27 → 2026-07-26
P/E Ratio
Earnings Yield
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
P/E Ratio
20.39
Earnings Yield (E/P)
0.0969
Price / Sales
5.92
Price / Book
1.75
Price / Cash Flow
14.55
FCF Yield
11.9%
EBITDA / EV
11.6%
Sales Yield (1/P·S)
0.2856
Shareholder Yield
Div + net buyback / mktcap
5.7%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
8.6%
Return on Assets
8.4%
Net Margin
29.0%
Operating Margin
33.9%
Gross Profit / Assets
Novy-Marx GPA
15.9%
Debt / Equity
0.02
Current Ratio
48.62
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.034
External Financing
Net issuance — lower=better
0.067
MomentumPrice trend strength over different horizons
6M Return
10.7%
12M Return
17.0%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
28.9%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
1.13
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
-7.0%
Earnings Growth (YoY)
-16.5%
Earnings Stability (CV)
Lower = more stable
0.117
5yr Consistent
EPS up every year for 5 years
Yes
Piotroski F-Score
6
Dividend Yield
1.8%
Buyback Yield
3.9%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
69
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
35
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
66
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity